HUNDREDS of women with ovarian cancer will benefit from a new NHS drug in the biggest breakthrough against the disease for ...
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...
A new targeted ovarian cancer treatment is helping women with hard-to-treat disease live longer, feel better, and gain ...
The Print on MSN
Frozen price caps, soaring platinum cost cause shortage of 2 key chemotherapy drugs in India
The two drugs, platinum-based chemotherapy agents, feature in treatment protocols for at least eight major cancer types.
Hosted on MSN
Nanomedicine researchers restructure common chemo drug to boost its power by 20,000-fold
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and ...
Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...
FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU ...
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results